Neutral and positively charged thiols synergize the effect of the immunomodulator AS101 as a growth inhibitor of Jurkat cells, by increasing its uptake

Biochemical Pharmacology

Volumn 74, Issue 5, 2007, Pages 712-722

  Frei, Gabi M ^a   Lebenthal, Ilana ^a   Albeck, Michael ^a   Albeck, Amnon ^a   Sredni, Benjamin ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

Antitumoral; AS101; Jurkat; ROS; Tellurium(IV); Thiols

Indexed keywords

AMMONIUM TRICHLORO(DIOXYETHYLENE O,O')TELLURATE; CARBOXYL GROUP; CASPASE 3; CASPASE 9; CATALASE; CYSTEINE; GLUTATHIONE; MERCAPTAMINE; MERCAPTOETHANOL; REACTIVE OXYGEN METABOLITE; TELLURIUM; THIOL DERIVATIVE;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKEMIA CELL LINE; MEMBRANE POTENTIAL; PRIORITY JOURNAL; SPECTROSCOPY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CYSTEAMINE; CYSTEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ETHYLENES; GLUTATHIONE; HUMANS; IMMUNOLOGIC FACTORS; JURKAT CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MERCAPTOETHANOL; REACTIVE OXYGEN SPECIES; SULFHYDRYL COMPOUNDS;

EID: 34447647680     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.05.011     Document Type: Article

References (36)

1. Schroeder H.A., Buckman J., and Balassa J.J. Abnormal trace elements in man: tellurium. J Chronic Dis 20 (1967) 147-161
2. Larner A.J. Tellurium in Health and Disease (1996), The Bulletin of Selenium-Tellurium Development Association
3. Cowgill U.M. The tellurium content of vegetation. Biol Trace Elem Res 17 (1988) 43-67
4. Sredni B., Caspi R.R., Klein A., Kalechman Y., Danziger Y., Ben Ya'akov M., et al. A new immunomodulating compound (AS-101) with potential therapeutic application. Nature 330 (1987) 173-176
5. Hayun M., Naor Y., Weil M., Albeck M., Peled A., Don J., et al. The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: association with the Akt/survivin pathway. Biochem Pharmacol 72 (2006) 1423-1431
6. Kalechman Y., Albeck M., Oron M., Sobelman D., Gurwith M., Horwith G., et al. Protective and restorative role of AS101 in combination with chemotherapy. Cancer Res 51 (1991) 1499-1503
7. Sredni B., Albeck M., Tichler T., Shani A., Shapira J., Bruderman I., et al. Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide. J Clin Oncol 13 (1995) 2342-2353
8. Albeck A., Weitman H., Sredni B., and Albeck M. Tellurium compounds: Selective inhibition of cysteine proteases and model reaction with thiols. Inorg Chem 37 (1998) 1704-1712
9. Nogueira C.W., Zeni G., and Rocha J.B. Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem Rev 104 (2004) 6255-6285
10. Sredni B., Gal R., Cohen I.J., Dazard J.E., Givol D., Gafter U., et al. Hair growth induction by the Tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression. FASEB J 18 (2004) 400-402
11. Sredni B., Geffen-Aricha R., Duan W., Albeck M., Shalit F., Lander H.M., et al. Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models. FASEB J (2007)
12. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., and Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139 (1991) 271-279
13. Smiley S.T., Reers M., Mottola-Hartshorn C., Lin M., Chen A., Smith T.W., et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA 88 (1991) 3671-3675
14. Legrand O., Perrot J.Y., Simonin G., Baudard M., and Marie J.P. JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia. Blood 97 (2001) 502-508
15. Ishii T., Bannai S., and Sugita Y. Mechanism of growth stimulation of L1210 cells by 2-mercaptoethanol in vitro. Role of the mixed disulfide of 2-mercaptoethanol and cysteine. J Biol Chem 256 (1981) 12387-12392
16. Broome J.D., and Jeng M.W. Promotion of replication in lymphoid cells by specific thiols and disulfides in vitro. Effects on mouse lymphoma cells in comparison with splenic lymphocytes. J Exp Med 138 (1973) 574-592
17. Scharrer E., Senn E., and Wolffram S. Stimulation of mucosal uptake of selenium from selenite by some thiols at various sites of rat intestine. Biol Trace Elem Res 33 (1992) 109-120
18. Cryns V., and Yuan J. Proteases to die for. Genes Dev 12 (1998) 1551-1570
19. Cohen G.M. Caspases: the executioners of apoptosis. Biochem J 326 Pt 1 (1997) 1-16
20. Hampton M.B., and Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett 414 (1997) 552-556
21. Chandra J., Samali A., and Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29 (2000) 323-333
22. Nakazato T., Ito K., Ikeda Y., and Kizaki M. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. Clin Cancer Res 11 (2005) 6040-6049
23. Gao N., Rahmani M., Dent P., and Grant S. 2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process. Oncogene 24 (2005) 3797-3809
24. Ghose A., Fleming J., and Harrison P.R. Selenium and signal transduction: roads to cell death and anti-tumour activity. Biofactors 14 (2001) 127-133
25. Yan L., Yee J.A., Boylan L.M., and Spallholz J.E. Effect of selenium compounds and thiols on human mammary tumor cells. Biol Trace Elem Res 30 (1991) 145-162
26. Painter E.P. Chem Rev 28 (1941) 179
27. Ganther H.E. Selenotrisulfides. Formation by the reaction of thiols with selenious acid. Biochemistry 7 (1968) 2898-2905
28. Simon H.U., Haj-Yehia A., and Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5 (2000) 415-418
29. Atmaca G. Antioxidant effects of sulfur-containing amino acids. Yonsei Med J 45 (2004) 776-788
30. De Flora S., Izzotti A., D'Agostini F., and Cesarone C.F. Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer. Am J Med 91 (1991) 122S-130S
31. Huang Y., and Sadee W. Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells. Cancer Lett 239 (2006) 168-182
32. Kanai Y., and Endou H. Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity. J Toxicol Sci 28 (2003) 1-17
33. Uchino H., Kanai Y., Kim D.K., Wempe M.F., Chairoungdua A., Morimoto E., et al. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharmacol 61 (2002) 729-737
34. Chasteen T.G., and Bentley R. Biomethylation of selenium and tellurium: microorganisms and plants. Chem Rev 103 (2003) 1-25
35. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., and Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 179 (1973) 588-590
36. Cunha R.L., Urano M.E., Chagas J.R., Almeida P.C., Bincoletto C., Tersariol I.L., et al. Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B. Bioorg Med Chem Lett 15 (2005) 755-760